Malcolm Johnson

7.7k total citations · 1 hit paper
84 papers, 6.1k citations indexed

About

Malcolm Johnson is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Malcolm Johnson has authored 84 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Physiology, 43 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Malcolm Johnson's work include Asthma and respiratory diseases (60 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Respiratory and Cough-Related Research (16 papers). Malcolm Johnson is often cited by papers focused on Asthma and respiratory diseases (60 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Respiratory and Cough-Related Research (16 papers). Malcolm Johnson collaborates with scholars based in United Kingdom, United States and Italy. Malcolm Johnson's co-authors include Peter K. Jeffery, Jean Bousquet, ANTONIO M. VIGNOLA, C.J. Vardey, Robert A. Coleman, Sebastian L. Johnston, Michael R. Edwards, Anthony T. Nials, Peter R. Butchers and C. J. Whelan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Malcolm Johnson

82 papers receiving 5.9k citations

Hit Papers

Asthma: From Bronchoconstriction to Airways Inflammation ... 2000 2026 2008 2017 2000 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm Johnson United Kingdom 40 3.9k 3.2k 1.2k 963 564 84 6.1k
Jun Tamaoki Japan 34 2.0k 0.5× 2.0k 0.6× 1.0k 0.8× 536 0.6× 355 0.6× 205 4.4k
Johan Kips Belgium 37 3.7k 0.9× 2.3k 0.7× 494 0.4× 1.4k 1.4× 1.1k 1.9× 101 5.1k
Julio Cortijo Spain 45 2.0k 0.5× 2.9k 0.9× 2.2k 1.8× 938 1.0× 182 0.3× 261 6.8k
Mark A. Birrell United Kingdom 45 2.4k 0.6× 2.2k 0.7× 1.8k 1.5× 1.2k 1.3× 260 0.5× 124 6.1k
Richard W. Chapman United States 33 2.0k 0.5× 1.3k 0.4× 760 0.6× 1.3k 1.4× 560 1.0× 128 4.1k
B. Boris Vargaftig France 41 1.9k 0.5× 1.0k 0.3× 1.3k 1.1× 1.1k 1.1× 493 0.9× 177 5.7k
Barbro Dahlén Sweden 47 4.8k 1.2× 3.0k 0.9× 711 0.6× 1.5k 1.6× 1.9k 3.3× 148 7.1k
Esteban Morcillo Spain 39 1.6k 0.4× 1.7k 0.5× 1.7k 1.4× 767 0.8× 138 0.2× 192 4.9k
B.B. Vargaftig France 36 1.8k 0.5× 921 0.3× 809 0.7× 1.0k 1.1× 655 1.2× 152 4.2k
Alaina J. Ammit Australia 42 1.7k 0.4× 897 0.3× 2.1k 1.7× 1.5k 1.5× 266 0.5× 123 5.7k

Countries citing papers authored by Malcolm Johnson

Since Specialization
Citations

This map shows the geographic impact of Malcolm Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Johnson more than expected).

Fields of papers citing papers by Malcolm Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Johnson. The network helps show where Malcolm Johnson may publish in the future.

Co-authorship network of co-authors of Malcolm Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Johnson. A scholar is included among the top collaborators of Malcolm Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Johnson. Malcolm Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asai, Kazuhisa, et al.. (2015). Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 4 indexed citations
2.
Mallia, Patrick, Simon Message, Marco Contoli, et al.. (2013). Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease. Respiratory Medicine. 108(1). 78–85. 16 indexed citations
3.
Mallia, Patrick, Joseph Footitt, Annette Jepson, et al.. (2012). Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 186(11). 1117–1124. 194 indexed citations
4.
Holden, Neil S., Christopher F. Rider, Elizabeth M. King, et al.. (2011). β 2 -Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proceedings of the National Academy of Sciences. 108(49). 19713–19718. 69 indexed citations
5.
Rossios, Christos, Yasuo To, Masako To, et al.. (2011). Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells. European Journal of Pharmacology. 670(1). 244–251. 52 indexed citations
6.
Mallia, Patrick, Simon Message, Vera Gielen, et al.. (2010). Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation. American Journal of Respiratory and Critical Care Medicine. 183(6). 734–742. 289 indexed citations
8.
Usmani, Omar S., Kazuhiro Ito, Kittipong Maneechotesuwan, et al.. (2005). Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy. American Journal of Respiratory and Critical Care Medicine. 172(6). 704–712. 173 indexed citations
9.
Edwards, Michael R., Tatiana Kebadze, Malcolm Johnson, & Sebastian L. Johnston. (2005). New treatment regimes for virus-induced exacerbations of asthma. Pulmonary Pharmacology & Therapeutics. 19(5). 320–334. 22 indexed citations
10.
Edwards, Michael R., Naofumi Mukaida, Malcolm Johnson, & Sebastian L. Johnston. (2005). IL-1β induces IL-8 in bronchial cells via NF-κB and NF-IL6 transcription factors and can be suppressed by glucocorticoids. Pulmonary Pharmacology & Therapeutics. 18(5). 337–345. 36 indexed citations
11.
Johnson, Malcolm. (2004). Interactions between Corticosteroids and β2-Agonists in Asthma and Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 1(3). 200–206. 54 indexed citations
12.
Howarth, Peter, Alan J. Knox, Yassine Amrani, et al.. (2004). Synthetic responses in airway smooth muscle. Journal of Allergy and Clinical Immunology. 114(2). S32–S50. 126 indexed citations
13.
Bousquet, Jean, et al.. (2000). Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling. American Journal of Respiratory and Critical Care Medicine. 161(5). 1720–1745. 1389 indexed citations breakdown →
14.
Johnson, Malcolm. (1998). The β -Adrenoceptor. American Journal of Respiratory and Critical Care Medicine. 158(Supplement_2). S146–S153. 300 indexed citations
15.
Johnson, Malcolm, et al.. (1998). Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. European Respiratory Journal. 11(1). 86–90. 55 indexed citations
16.
Johnson, Malcolm. (1998). Development of fluticasone propionate and comparison with other inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 101(4). S434–S439. 97 indexed citations
17.
Rayner, C F, A Rutman, A D Jackson, et al.. (1997). Effect of Salmeterol on Pseudomonas Aeruginosa Infection of Respiratory Mucosa. American Journal of Respiratory and Critical Care Medicine. 155(1). 327–336. 57 indexed citations
18.
Green, Stuart A., et al.. (1996). Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding. Journal of Biological Chemistry. 271(39). 24029–24035. 123 indexed citations
19.
Johnson, Malcolm. (1995). Salmeterol. Medicinal Research Reviews. 15(3). 225–257. 57 indexed citations
20.
Johnson, Malcolm. (1995). The anti‐inflammatory profile of fluticasone propionate. Allergy. 50(s23). 11–14. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026